The particle therapy market size has grown rapidly in recent years. It will grow from $1.11 billion in 2023 to $1.26 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth witnessed in the past period can be attributed to progress in clinical research and studies, an increase in cancer incidence rates, government support and financial backing, industry collaboration, and improvements in treatment planning.
The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $1.95 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The anticipated growth in the forecast period can be linked to a surge in healthcare expenditure, the emergence of applications extending beyond cancer, a rise in the geriatric population, ongoing healthcare infrastructure development, and the integration of AI and data analytics. Noteworthy trends expected during this period encompass advancements in particle accelerator technology, the adoption of hypofractionation techniques, the exploration of proton and carbon ion combination therapy, enhancements in patient comfort, and the implementation of biology-driven treatment protocols.
The anticipated growth of the particle therapy market is poised to be propelled by the increasing prevalence of cancer. Cancer, a complex and diverse group of diseases characterized by abnormal cell growth and proliferation in the body, is expected to drive demand for particle therapy. This form of treatment utilizes precise and effective radiation, employing accelerated positively charged particles (protons) focused on the tumor. In February 2021, reports from John Wiley & Sons Inc., a US-based publishing company, indicated a global estimate of 19.3 million new cancer cases and almost 10.0 million cancer deaths in 2020. The growth of cancer cases, as highlighted by the Centers for Disease Control and Prevention in May 2022, with 1.60 million new cases and 602,347 cancer-related deaths in the US alone in 2020, underscores the pivotal role of particle therapy in addressing this health challenge. With 403 new cancer cases and 144 cancer-related deaths recorded per 100,000 people, the rising prevalence of cancer is a key driver for the growth of the particle therapy market.
The growth in the particle therapy market is expected to be further propelled by the increasing aging population. This demographic trend, characterized by a growing proportion of elderly individuals in society, is expected to boost demand for particle therapy. Particle therapy is particularly significant for the geriatric population, offering a precise and targeted approach to cancer treatment. This minimizes damage to surrounding healthy tissues, reduces the risk of long-term side effects, and enhances the overall quality of life for elderly patients undergoing cancer therapy. According to the World Health Organization in October 2022, projections indicate that by 2030, 1 out of every 6 individuals globally would be 60 years old or older. During this period, the proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the aging population is a significant driver for the particle therapy market.
An emerging trend gaining traction in the particle therapy market is the adoption of advanced particle therapy platforms. Major players in the market are actively engaged in the development of innovative platforms to maintain and strengthen their market positions. Notably, in October 2021, Ion Beam Applications S.A. (IBA), a medical technology company based in Belgium, introduced the world's first online proton therapy platform. This web-based platform offers a diverse range of resources, including educational materials on proton therapy, discussion forums, and information on clinical trials. Additionally, the platform features a virtual reality (V.R.) tour of a proton therapy center, allowing users to experience the process of receiving proton therapy. This comprehensive platform serves as a valuable tool for clinicians, researchers, and patients dedicated to improving the lives of individuals affected by cancer.
Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.
In May 2022, Brainlab AG, a Germany-based medical technology company, acquired a majority stake in medPhoton GmbH for an undisclosed amount. This strategic acquisition aims to expand Brainlab's intraoperative imaging portfolio, drive business growth, bolster product development, and accelerate innovation in the critical field of medical technology. medPhoton GmbH, an Austria-based medical equipment manufacturing company, specializes in providing particle therapy devices and services.
Major companies operating in the particle therapy market report are Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy PLC, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.
North America was the largest region in the particle therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.
The particle therapy market research report is one of a series of new reports that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $1.95 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The anticipated growth in the forecast period can be linked to a surge in healthcare expenditure, the emergence of applications extending beyond cancer, a rise in the geriatric population, ongoing healthcare infrastructure development, and the integration of AI and data analytics. Noteworthy trends expected during this period encompass advancements in particle accelerator technology, the adoption of hypofractionation techniques, the exploration of proton and carbon ion combination therapy, enhancements in patient comfort, and the implementation of biology-driven treatment protocols.
The anticipated growth of the particle therapy market is poised to be propelled by the increasing prevalence of cancer. Cancer, a complex and diverse group of diseases characterized by abnormal cell growth and proliferation in the body, is expected to drive demand for particle therapy. This form of treatment utilizes precise and effective radiation, employing accelerated positively charged particles (protons) focused on the tumor. In February 2021, reports from John Wiley & Sons Inc., a US-based publishing company, indicated a global estimate of 19.3 million new cancer cases and almost 10.0 million cancer deaths in 2020. The growth of cancer cases, as highlighted by the Centers for Disease Control and Prevention in May 2022, with 1.60 million new cases and 602,347 cancer-related deaths in the US alone in 2020, underscores the pivotal role of particle therapy in addressing this health challenge. With 403 new cancer cases and 144 cancer-related deaths recorded per 100,000 people, the rising prevalence of cancer is a key driver for the growth of the particle therapy market.
The growth in the particle therapy market is expected to be further propelled by the increasing aging population. This demographic trend, characterized by a growing proportion of elderly individuals in society, is expected to boost demand for particle therapy. Particle therapy is particularly significant for the geriatric population, offering a precise and targeted approach to cancer treatment. This minimizes damage to surrounding healthy tissues, reduces the risk of long-term side effects, and enhances the overall quality of life for elderly patients undergoing cancer therapy. According to the World Health Organization in October 2022, projections indicate that by 2030, 1 out of every 6 individuals globally would be 60 years old or older. During this period, the proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the aging population is a significant driver for the particle therapy market.
An emerging trend gaining traction in the particle therapy market is the adoption of advanced particle therapy platforms. Major players in the market are actively engaged in the development of innovative platforms to maintain and strengthen their market positions. Notably, in October 2021, Ion Beam Applications S.A. (IBA), a medical technology company based in Belgium, introduced the world's first online proton therapy platform. This web-based platform offers a diverse range of resources, including educational materials on proton therapy, discussion forums, and information on clinical trials. Additionally, the platform features a virtual reality (V.R.) tour of a proton therapy center, allowing users to experience the process of receiving proton therapy. This comprehensive platform serves as a valuable tool for clinicians, researchers, and patients dedicated to improving the lives of individuals affected by cancer.
Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.
In May 2022, Brainlab AG, a Germany-based medical technology company, acquired a majority stake in medPhoton GmbH for an undisclosed amount. This strategic acquisition aims to expand Brainlab's intraoperative imaging portfolio, drive business growth, bolster product development, and accelerate innovation in the critical field of medical technology. medPhoton GmbH, an Austria-based medical equipment manufacturing company, specializes in providing particle therapy devices and services.
Major companies operating in the particle therapy market report are Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy PLC, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.
North America was the largest region in the particle therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.
The particle therapy market research report is one of a series of new reports that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Particle Therapy Market Characteristics3. Particle Therapy Market Trends and Strategies32. Global Particle Therapy Market Competitive Benchmarking33. Global Particle Therapy Market Competitive Dashboard34. Key Mergers and Acquisitions in the Particle Therapy Market
4. Particle Therapy Market - Macro Economic Scenario
5. Global Particle Therapy Market Size and Growth
6. Particle Therapy Market Segmentation
7. Particle Therapy Market Regional and Country Analysis
8. Asia-Pacific Particle Therapy Market
9. China Particle Therapy Market
10. India Particle Therapy Market
11. Japan Particle Therapy Market
12. Australia Particle Therapy Market
13. Indonesia Particle Therapy Market
14. South Korea Particle Therapy Market
15. Western Europe Particle Therapy Market
16. UK Particle Therapy Market
17. Germany Particle Therapy Market
18. France Particle Therapy Market
19. Italy Particle Therapy Market
20. Spain Particle Therapy Market
21. Eastern Europe Particle Therapy Market
22. Russia Particle Therapy Market
23. North America Particle Therapy Market
24. USA Particle Therapy Market
25. Canada Particle Therapy Market
26. South America Particle Therapy Market
27. Brazil Particle Therapy Market
28. Middle East Particle Therapy Market
29. Africa Particle Therapy Market
30. Particle Therapy Market Competitive Landscape and Company Profiles
31. Particle Therapy Market Other Major and Innovative Companies
35. Particle Therapy Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Particle Therapy Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on particle therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for particle therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:1) By Type: Proton Therapy; Heavy Ion Therapy
2) By System: Single-Room Systems; Multi-Room Systems
3) By Cancer Type: Pediatric Cancer; Prostate Cancer; Lung Cancer; Breast Cancer; Brain and Spinal Cord Cancer; Other Cancer Types
4) By End-user: Hospital; Academic and Research Centers
Key Companies Mentioned: Hitachi Ltd.; Mitsubishi Electric Corporation; Siemens Healthineers AG; Koninklijke Philips N.V; GE Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned
- Hitachi Ltd.
- Mitsubishi Electric Corporation
- Siemens Healthineers AG
- Koninklijke Philips N.V
- GE Healthcare
- Sumitomo Heavy Industries Ltd.
- Varian Medical Systems Inc.
- Elekta AB
- Shinva Medical Instrument Co. Ltd.
- Toshiba Medical Systems Corporation
- Brainlab AG
- Accuray Incorporated
- IBA Worldwide
- Mevion Medical Systems Inc.
- Avante Health Solutions
- Provision Healthcare LLC
- ViewRay
- Panacea Biotec Ltd.
- PTW Freiburg GmbH.
- ProNova Solutions LLC
- Optivus Proton Therapy Inc.
- Xstrahl Inc.
- Protom International Inc.
- Danfysik AS
- SAH Global LLC
- Advanced Oncotherapy plc
- Particle Therapy Co-Operative Group
- Best Particle Therapy Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | February 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 1.26 Billion |
| Forecasted Market Value ( USD | $ 1.95 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
